98%
921
2 minutes
20
Current research on healthcare-associated infection (HAI) surveillance in traditional Korean medicine (TKM) institutions is limited. We utilized the Delphi method to evaluate the validity and feasibility of implementing an HAI surveillance system in TKM hospitals. This involved conducting a systematic literature review and focus group interviews with three infection control experts and five TKM doctors experienced in infection control within TKM hospitals. Based on these findings, we developed a Delphi questionnaire. The survey included a total of fifteen participants: ten TKM doctors and TKM-related policy researchers with infection control expertise, two infection control nurses, and three infectious disease doctors. The survey results indicated strong consensus on the necessity of introducing an HAI surveillance system tailored to TKM hospitals, as well as their integration into the Korean National Healthcare-associated Infections Surveillance (KONIS) system. Since infectious diseases do not differentiate between acute care hospitals and TKM hospitals, it is reasonable for TKM hospitals to participate in infection surveillance systems. However, the feasibility of implementing HAI surveillance in TKM hospitals remains low due to a lack of awareness regarding infection surveillance, insufficient surveillance personnel, inadequate diagnostic and surveillance infrastructure, and limited policy support for infection control. Therefore, this study proposes a phased approach in which hand hygiene surveillance and safe injection practice monitoring, which received relatively higher consensus on feasibility, should be prioritized to establish the necessary surveillance infrastructure. Subsequently, a stepwise implementation of HAI surveillance can be introduced. Although TKM hospitals generally have a lower risk of HAIs compared to acute care facilities, they lack robust infection control systems and support. To address this gap, TKM hospitals should join the KONIS system. Appointing and training dedicated infection control personnel will enable their participation and enhance overall infection management.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12071445 | PMC |
http://dx.doi.org/10.3390/healthcare13090991 | DOI Listing |
World J Clin Cases
September 2025
Department of Korean Neuropsychiatry Medicine, Wonkwang University, Iksan, Jeollabuk-do 54538, South Korea.
Background: Mild cognitive impairment (MCI) and subjective cognitive decline (SCD) are risk indicators for dementia and require ongoing management. Traditional Korean medicine (TKM) commonly employs acupuncture and herbal medicine for cognitive impairment; yet, clinical research on acupotomy is lacking. Although most TKM treatments occur in primary care, the research is largely hospital-based.
View Article and Find Full Text PDFJ Vasc Interv Radiol
July 2025
Department of Palliative Medicine, National Cancer Center H Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo 1040045, Japan.
Intern Med
July 2025
Department of Psychiatric Medicine, Sapporo Suzuki Hospital, Medical Corporation Kenseikai, Japan.
Despite antiviral administration, a small number of patients still suffer from prolonged and severe COVID-19 owing to excessive inflammation. Traditional Kampo medicines (TKMs) with a heat-clearing effect have anti-inflammatory effects, such as a reduced NF-κB activity, and rarely cause serious side effects when administered for a short period of time. After oral administration, TKMs interact with the gut microbiota, producing two types of metabolites: metabolites from the gut microbiota (of food and host origin) and TKM compounds transformed by the gut microbiota.
View Article and Find Full Text PDFCell Rep Med
June 2025
Dr. Senckenberg Institute of Neurooncology, University Hospital, Goethe University Frankfurt, Frankfurt, Germany.
Lisavanbulin is a prodrug of the microtubule-targeting agent avanbulin. Both avanbulin and lisavanbulin have demonstrated significant antitumor activity in several preclinical tumor models including glioblastoma. Previous human studies demonstrated that 48-h infusions of intravenous lisavanbulin were well tolerated with preliminary activity in recurrent glioblastoma.
View Article and Find Full Text PDFBrain Med
May 2025
Department of Internal Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, 01307 Dresden, Germany.
Microplastics and nanoplastics have emerged as a major and growing health concern, with recent data revealing alarming levels of human exposure and contamination. Thus, there is a clear and urgent need for an effective method to remove microplastics and nanoplastics from the human body. Here, we provide the first evidence that extracorporeal apheresis, a therapeutic technique established around the world, may have the potential to achieve this goal.
View Article and Find Full Text PDF